Blood Thinner May Slow Cognitive Decline in Alzheimer’s Patients With AFib
Recent research from Sweden indicates that a class of blood thinners known as non-vitamin K antagonist oral anticoagulants (NOACs) may play a crucial role in slowing cognitive decline among Alzheimer’s patients who also suffer from atrial fibrillation (AFib). This study suggests that these modern blood thinners not only serve to prevent strokes but may also…
